Related Experiment Video
Updated: Aug 11, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Epithelial-mesenchymal transition in Crohn's disease
1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center; Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai Institute of Digestive Disease, Shanghai, China.
Epithelial-mesenchymal transition (EMT) drives Crohn's disease complications like fistulas and fibrosis. Understanding EMT offers new therapeutic targets for these challenging conditions.
Area of Science:
- Gastroenterology
- Cell Biology
- Pathogenesis Research
Background:
- Crohn's disease (CD) frequently presents with intestinal strictures and fistulas, complicating treatment.
- Epithelial-mesenchymal transition (EMT) is increasingly recognized as a key factor in CD pathogenesis.
- EMT involves epithelial cells losing adhesion and gaining migratory and fibroblast-like properties.
Purpose of the Study:
- To review current knowledge on epithelial-mesenchymal transition (EMT).
- To elucidate the role of EMT in the pathogenesis of Crohn's disease complications.
- To identify potential new therapeutic targets for CD-associated fistulas and fibrosis.
Main Methods:
- Literature review of studies on epithelial-mesenchymal transition (EMT) in Crohn's disease.
- Analysis of the mechanisms by which EMT contributes to fistula formation and fibrosis.
- Synthesis of current understanding of EMT's role in CD pathogenesis.
Main Results:
- During fistula formation, intestinal epithelial cells migrate and transform into transitional cells in response to poor wound healing.
- EMT contributes to intestinal fibrosis in CD by generating new fibroblasts and promoting extracellular matrix overproduction.
- EMT is a critical cellular process underlying major complications in Crohn's disease.
Conclusions:
- Epithelial-mesenchymal transition plays a significant role in the development of fistulas and fibrosis in Crohn's disease.
- Targeting EMT pathways presents a promising strategy for managing CD-associated intestinal complications.
- Further research into EMT mechanisms could lead to novel therapeutic interventions for Crohn's disease patients.
More Related Videos
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
The Tumor Microenvironment
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease